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OBJECTIVES We evaluated the clinical characteristics and outcomes of elderly patients hospitalized with
acute myocardial infarction (AMI) to describe differences by age.
BACKGROUND Elderly patients with AMI are perceived as a homogeneous population, though the extent by
which clinical characteristics vary among elderly patients has not been well described.
METHODS Data from 163,140 hospital admissions of Medicare beneficiaries age $65 years between
1994 and 1996 with AMI at U.S. hospitals were evaluated for differences in clinical
characteristics and mortality across five age-based strata (in years): 65 to 69, 70 to 74, 75 to
79, 80 to 84 and $85.
RESULTS Older age was associated with a greater proportion of patients with functional limitations,
heart failure, prior coronary disease and renal insufficiency and a lower proportion of male and
diabetic patients. Of note, the proportion of patients presenting with chest pain within 6 h
of symptom onset, and with ST-segment elevation, was lower in each successive age group.
Thirty-day mortality rates were higher in older age groups (65 to 69: 10.9%, 70 to 74: 14.1%,
75 to 79: 18.5%, 80 to 84: 23.2%, $85: 31.2%, p 5 0.001 for trend). The effect of age
persisted but was attenuated after adjustment for differences in patient characteristics; similar
trends were observed for one-year mortality.
CONCLUSIONS Our data indicate significant age-associated differences in clinical characteristics in elderly
patients with AMI, which account for some of the age-associated differences in mortality.
The practice of grouping older patients together as a single age group may obscure important
age-associated differences. (J Am Coll Cardiol 2001;38:736–41) © 2001 by the American
College of Cardiology
Elderly patients, those 65 years of age and older, represent
13% of the U.S. population yet account for half of hospital
admissions for acute myocardial infarction (AMI) and 80%
of AMI deaths (1). Despite the greater risk of AMI among
older patients and the increasing size of this population (1),
the relationship between age, clinical presentation and
outcome of AMI in elderly patients is incompletely under-
stood. Many prior observational studies and clinical trials
have classified elderly patients as a single population, not
specifically evaluating differences in older subgroups, partic-
ularly those 75 years of age and older (2–13). The few
studies that have explored age-associated differences in
AMI presentation and outcomes in this cohort have been
limited to small numbers of very elderly patients, usually
drawn from individual centers or regions (3,5,7).
Accordingly, we sought to determine how clinical char-
acteristics and outcomes of elderly patients hospitalized with
AMI vary by age. Using data from the Cooperative Car-
diovascular Project (CCP), a cohort of Medicare beneficia-
ries hospitalized with AMI, we evaluated variations in
clinical characteristics of elderly patients by age, the rela-
tionship of age, 30-day and one-year outcomes and the
extent to which increased mortality was explained by age-
associated variations in clinical characteristics. We antici-
pated that, rather than representing a homogeneous popu-
lation, patients 65 years of age and older would exhibit
significant differences in clinical characteristics by age and
that higher mortality rates would be explained, in part, by
differences in patients’ clinical characteristics and treatment.
METHODS
Study sample. The CCP sampling strategy has been ex-
plained previously (14). We evaluated patients age 65 years
and older hospitalized with a confirmed AMI (15). Patients
less than 65 years of age (n 5 17,593), those without a
confirmed AMI (n 5 31,186), readmissions for AMI (n 5
23,773) and patients transferred from another acute care
hospital (n 5 36,297) were excluded. In total, 71,629
(30.5%) hospitalizations met one or more of the exclusion
criteria; the remaining 163,140 patients constitute the study
sample.
Age stratification and patient characteristics. We cate-
gorized patients into five groups based on their age (years):
65 to 69, 70 to 74, 75 to 79, 80 to 84 and 85 and older. Most
demographic and clinical characteristics were abstracted as
categorical variables in the CCP database. Missing categor-
ical data elements were assumed to be negative for the
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variable. Missing values for continuous variables were im-
puted by the median value of the variable, and a separate
indicator was used if the percentage of missing values
(serum albumin, left ventricular ejection fraction) was more
than 5%. Continuous variables were then dichotomized or
categorized based on clinical significance. A history of AMI,
percutaneous transluminal coronary angioplasty (PTCA),
coronary artery bypass grafting (CABG) or congestive heart
failure was considered to be evidence of prior coronary
artery disease. Renal insufficiency was defined as blood urea
nitrogen level .50 mg/dl, or creatinine .2.0 mg/dl on
admission (for renal insufficiency as a comorbidity) or
highest creatinine .2.0 mg/dl during the hospital stay (for
renal insufficiency as a complication). Functional status was
considered to be impaired if the patient was unable to
ambulate without assistance, was incontinent, or if dementia
was present. Heart failure was present on admission if
documented by a physician or on the admission chest
radiograph interpretation. Patients were also evaluated for
use of AMI therapies.
Hospital characteristics, physician characteristics and
outcomes. Hospitals were characterized by linking records
with the 1994 American Hospital Association Survey (16).
The specialty of the attending physician was determined by
linking records to a database of physician-reported special-
ties obtained from the Health Care Financing Administra-
tion (17,18). Patient mortality was determined by linking
records with the Medicare Enrollment Database (19).
Statistical methods. We first examined the association of
patient characteristics and older age by chi-square tests and
analyses of variance, testing for both global differences and
trends by age. Crude patient outcomes were compared
across age strata using bivariate analysis, and the indepen-
dent association of age with 30-day and one-year mortality
was evaluated sequentially by multivariable logistic regres-
sion analyses adjusted for patient and hospital characteris-
tics, physician specialty, medical therapy use and clustering
of patients by hospital. SAS 6.12 software (SAS Institute
Inc., Cary, North Carolina) and STATA 6.0 software (Stata
Corporation, College Station, Texas) were used for analysis.
RESULTS
Patient characteristics. Older elderly patients hospitalized
with AMI were different than younger elderly patients. The
proportion of women in the oldest age group was almost
double that in the younger group, while nonwhite patients
were represented in smaller numbers. Diabetes, smoking,
chronic lung disease and a history of prior revascularization
were less frequently encountered in older patients. In
contrast, a history of heart failure, stroke, renal insufficiency
and laboratory evidence of comorbid conditions (low he-
matocrit, low serum sodium, low albumin) were consider-
ably higher in the older age groups. The proportion of
patients with limited functional status was higher in older
age groups, affecting almost half of patients age $85 years.
Older elderly patients presented less frequently with chest
pain, ST-segment elevation, left bundle branch block,
within 6 h of symptom onset, and had smaller enzymatic
evidence of ischemia (lower creatine kinase) than younger
elderly patients. In contrast, heart failure, tachycardia and
anterior location of infarct were more common in older
individuals (Table 1).
Characteristics of in-hospital care. Older patients were
more likely to be admitted to a facility without revas-
cularization capabilities, less likely to be cared for by a
cardiologist, undergo stress testing, left ventricular ejection
fraction assessment or invasive cardiovascular procedures
during hospitalization compared with younger patients.
Crude rates of aspirin, reperfusion therapy (thrombolytic or
primary PTCA) and beta-adrenergic blocking agent use
were also lower in older elderly patients (Table 2).
Complications and mortality. Cardiovascular complica-
tions, including hypotension, shock, atrial fibrillation, heart
failure and stroke and noncardiovascular complications,
including pneumonia and renal insufficiency on admission,
were more common in older patients. Older patients were
more likely to be discharged to a nonacute care facility and
less likely to be transferred to another acute-care facility
than younger elderly patients (Table 2).
Thirty-day and one-year mortality rates were markedly
higher for older elderly patients compared with younger
elderly patients, with a trend of successively higher mortality
in intermediate age groups (Fig. 1). Age-associated mortal-
ity risks were attenuated but persisted after adjustment for
patient, hospital and physician characteristics and AMI
care. Most of the attenuation was accounted for by patient
clinical characteristics and AMI care (Table 3).
DISCUSSION
This study provides a comprehensive national perspective
on the association of patient characteristics and outcomes by
age among a large representative sample of elderly patients
with AMI. We observed marked differences by age among
patients 65 years of age and older. This finding suggests that
the practice of grouping older patients together in a single
group of patients 65 years of age and older may provide a
perspective that is not representative of all patients in this
group. While statistically convenient when studies have
small numbers of older patients, the clinical relevance of this
approach is questionable.
Previous research has found that older age is associated
with a higher prevalence of comorbid conditions, atypical
AMI presentation, nondiagnostic electrocardiograms, com-
Abbreviations and Acronyms
AMI 5 acute myocardial infarction
CABG 5 coronary artery bypass graft
CCP 5 Cooperative Cardiovascular Project
PTCA 5 percutaneous transluminal coronary angioplasty
737JACC Vol. 38, No. 3, 2001 Mehta et al.
September 2001:736–41 Clinical Characteristics and AMI in the Elderly
Table 1. Patient Characteristics by Patient Age Group (%)
Characteristics
Age Groups (yrs)
65–69 70–74 75–79 80–84 851
n (%) 33,259 (20.6) 38,212 (23.7) 34,595 (21.4) 29,593 (18.3) 25,681 (15.9)
Female gender 37.5 42.7 48.7 55.8 65.0
Nonwhite race 12.2 10.5 9.1 8.4 8.0
Functional status (%)
Any functional impairment 11.3 15.3 23.0 32.1 48.0
Immobility 8.6 11.5 17.3 24.3 38.2
Incontinence 3.4 4.5 6.6 9.1 15.8
Dementia 1.2 2.4 5.4 9.1 14.8
Admission from chronic care/SNF 1.6 2.5 4.4 7.5 16.8
CAD history (%)
Any CAD history 41.6 44.6 47.1 48.6 51.4
Prior AMI* 28.2 29.4 29.5 29.6 28.5
Prior CABG 15.1 15.6 14.0 10.2 4.4
Prior PTCA 9.1 8.4 6.8 4.8 2.3
Prior CHF 13.0 16.2 20.7 26.3 34.6
Prior stroke 10.3 12.5 15.2 16.4 16.6
Medical history (%)
Hypertension 59.6 61.8 63.2 63.5 60.3
Diabetes 32.8 33.6 32.9 29.3 21.8
Terminal illness 1.6 2.0 2.4 2.3 2.4
Current smoker 27.4 18.9 12.3 7.8 3.5
COPD 20.9 21.5 21.7 19.9 16.3
Renal failure 6.6 8.5 10.5 12.8 15.9
Clinical presentation (%)
Angina at presentation 89.2 87.0 84.4 81.2 73.9
Angina ,6 h 58.4 56.1 53.4 49.7 43.4
Hypertension 31.8 32.3 31.8 31.2 27.6
Heart rate .100 beats/min 21.5 23.7 26.4 28.0 30.2
Heart failure 25.1 29.3 35.1 40.9 48.0
LVEF (unknown, ,25, 25–40, .40)† 32/5/14/49 33/6/15/47 34/6/16/44 39/6/16/39 47/6/15/32
Cardiomegaly 27.7 31.7 36.7 41.7 46.6
ECG characteristics (%)
Eligible for acute reperfusion‡ 31.5 30.0 27.7 25.7 22.3
ST-segment elevation 31.9 30.6 28.7 27.5 26.0
Left bundle branch block 4.1 5.3 6.7 7.9 9.5
Right bundle branch block 5.6 6.6 8.1 8.7 10.0
Atrial fibrillation 5.5 7.2 9.9 11.6 14.5
Ventricular tachycardia* 0.8 0.7 0.8 0.9 0.8
2nd/3rd degree heart block 1.2 1.3 1.4 1.4 1.6
Fascicular block 5.2 6.1 7.2 8.0 9.3
Paced rhythm 0.7 1.2 1.7 2.3 2.7
AMI location (%)
Anterior/septal AMI 43.9 45.1 46.7 48.2 49.6
Inferior/posterior AMI 54.0 51.5 48.3 44.8 40.2
Laboratory values (%)
Highest CK 5 times normal 33.4 32.6 30.0 27.8 26.6
Hematocrit ,30% 3.2 3.8 4.5 5.7 6.9
Serum sodium ,130 meq/liter 1.9 2.2 2.5 3.0 3.7
Serum albumin ,3 g/dl 3.4 3.8 4.4 4.8 5.7
Cardiac care facilities (%)†
CABG capable/catheterization
capable/no invasive facilities




37/31/16/18 35/34/17/17 32/36/18/16 28/38/20/15 23/42/23/14
*p 5 0.001 for test of trend unless otherwise noted; †may not equal 100 due to rounding; ‡ST-segment elevation or left bundle branch block and presentation within 6 h of
symptom onset.
AMI 5 acute myocardial infarction; CABG 5 coronary artery bypass graft surgery; CAD 5 coronary artery disease; CHF 5 congestive heart failure; CK 5 creatine kinase;
COPD 5 chronic obstructive pulmonary disease; ECG 5 electrocardiographic; LVEF 5 left ventricular ejection fraction; PTCA 5 percutaneous transluminal coronary
angioplasty; SNF 5 skilled nursing facility.
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plications and mortality (2–7,10–13,20–22). However,
these studies have typically enrolled small numbers of
patients, often from clinical trials and, thus, reflect the
experience of selected patient populations (2,6,12,13). The
clinical detail contained in the CCP allowed us to evaluate
characteristics of elderly AMI patients with an unprece-
dented level of detail in a cohort drawn from a nationally
representative population. Though some of our findings are
not surprising, CCP provides an opportunity to quantify the
association of age and patients’ characteristics in an older
group of patients.
Age-associated variation in AMI characteristics. Co-
morbidity varied by age, with some comorbid conditions less
prevalent in older elderly patients and others more preva-
lent. A lower prevalence of certain comorbid conditions in
older patients, such as diabetes or chronic lung disease, may
reflect a survivor effect with earlier mortality among those
with disease, leaving fewer patients with disease surviving to
older age. The lower prevalence of prior CABG or PTCA
in older subjects may indicate a survivor effect, but it may
alternatively represent historical practice patterns of fewer
coronary interventions when these patients were younger
and the current practice of limited procedure use in older
patients.
We observed significant variations in the clinical presen-
tation of AMI in elderly patients. Older elderly AMI
patients often presented without ST-segment elevation or
with electrocardiographic presentations that were difficult to
interpret, such as paced rhythms and left bundle branch
block. The combination of atypical symptoms, delayed
presentation and nondiagnostic electrocardiographic pre-
sentation indicates the difficulty in using traditional cues to
facilitate early triage and diagnosis. This observation may
account for the lower rates of therapy use in older elderly
patients. Variations in therapy use are likely further exacer-
bated by older elderly patients’ treatment at smaller hospi-
tals and management by nonspecialists (17,18,23–25).
Age-associated variation in AMI mortality. A large por-
tion of age-associated variation in mortality was attributable
to age-related variation in patients’ clinical characteristics
and AMI care, as adjustment for these factors resulted in the
Table 2. Myocardial Infarction Therapy Use, In-Hospital Course and Complications by Patient Age Group
Characteristics
Age Groups (yrs)
65–69 70–74 75–79 80–84 851
Medical therapy (%)
Reperfusion therapy 12.3 10.0 7.4 4.6 2.1
Aspirin during hospitalization 83.9 80.8 77.0 74.5 69.2
Beta-blockers during hospitalization 52.3 49.0 44.9 40.5 32.9
Coronary procedures (%)
Cardiac catheterization 65.2 58.4 46.6 28.6 9.7
Revascularization among those with catheterization 44.1 38.7 29.8 17.1 5.5
PTCA 28.3 23.8 18.0 11.4 4.3
CABG 20.0 18.4 14.3 7.0 1.5
Echocardiogram 54.1 56.1 58.6 59.0 54.7
MUGA 3.3 3.5 3.5 3.1 2.1
Stress test 14.5 13.4 12.1 9.8 4.4
Complications during hospitalization (%)
Hypotension* 23.3 23.6 24.3 24.4 25.6
Shock 6.5 7.3 8.1 8.4 8.9
Atrial fibrillation/flutter 12.9 16.4 21.3 24.2 28.8
CHF/pulmonary edema 36.2 41.4 49.1 56.5 64.6
Stroke 2.1 2.5 3.1 3.2 3.7
Renal insufficiency 10.7 13.5 16.5 19.7 22.8
Bleeding or hemorrhage 15.9 16.7 17.3 16.8 15.4
Transfusion given 11.6 13.0 13.0 11.6 9.6
Pneumonia 6.7 8.1 9.5 11.0 14.1
Discharge status-home/transfer/SNF/other† 64/31/5/0 65/28/7/0 66/24/10/0 67/16/17/0 61/6/33/0
Length of stay .10 days‡ 18.4 21.0 24.8 27.1 28.6
*p 5 0.001 for test of trend unless otherwise noted; †may not equal 100 due to rounding; ‡length of stay figure excludes patients who died during hospitalization, were transferred
out or underwent CABG during hospitalization.
CABG 5 coronary artery bypass graft surgery; CHF 5 congestive heart failure; MUGA 5 multiple gated acquisition; PTCA 5 percutaneous transluminal coronary
angioplasty; SNF 5 skilled nursing facility.
Figure 1. Crude 30-day and one-year mortality among different age groups
of elderly patients with acute myocardial infarction. Solid bar 5 30-day
unadjusted; spotted bar 5 one-year unadjusted; hatched bar 5 30-day
adjusted; open bar 5 one-year adjusted.
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greatest reduction in the age-associated odds of 30-day and
one-year mortality. Interestingly, adjustments for specialty
of the attending physician and hospital characteristics had
only a minor effect on age-associated variations in mortality,
suggesting that, while these factors may influence process of
care, they have a limited direct contribution to patient
outcomes among elderly patients. Nevertheless, even after
such adjustments, age remained an important predictor of
30-day and one-year mortality, with a relationship that
appeared linear.
The independent association of age with mortality likely
reflected the influence of many factors. Older age is associ-
ated with significant cardiovascular structural and physio-
logic changes that might predispose patients to adverse
outcomes, including abnormalities of left ventricular dia-
stolic function (26,27), decrease in systemic vascular com-
pliance (28), increase in left ventricular mass index (29) and
altered neurohormonal and autonomic influences (30,31).
Similarly, coagulation factors (VII, VIII and IX) are in-
creased compared with anticoagulation factors (antithrom-
bin III, Protein C and Protein S) with advancing age,
leading to a greater risk of thrombosis in older patients (32).
Whether adjustment for these and other important factors
(such as the severity of coronary artery disease) associated
with age and outcomes not accounted for in this study
would lead to further attenuation of the association between
age and mortality is unknown.
Study limitations. The design of the CCP precludes com-
parisons with representative patients younger than 65 years
of age. Our aim, however, was to illuminate differences in
characteristics among patients 65 years of age and older
since this group is commonly defined as a single group.
Additionally, while CCP was a national cohort, it did not
include patients enrolled in managed care. The exclusion of
managed care patients may have resulted in a healthier
cohort due to the increased enrollment of sicker patients in
health maintenance organizations (for purposes of obtaining
pharmaceutical benefits or other coverage) or a sicker cohort
due to the enrollment of healthier patients by risk-averse
health maintenance organizations. This issue is unlikely to
have substantially affected our main findings.
Conclusions. Patients 65 years of age and older with AMI
are a heterogeneous group by age. Studies that classify
elderly patients as a single population may overlook impor-
tant differences in elderly patients, particularly the oldest,
who are often excluded from clinical research studies.
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